King's College London

Research portal

Lancet, ‎0140-6736

Journal

  1. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

    Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., Franssen, F. M. E., Frey, U., Han, M. L., Hansel, N. N., Hawkins, N. M., Kalhan, R., Konigshoff, M., Ko, F. W., Parekh, T. M., Powell, P., & 9 othersRutten-van Mölken, M., Simpson, J., Sin, D. D., Song, Y., Suki, B., Troosters, T., Washko, G. R., Welte, T. & Dransfield, M. T., 17 Sep 2022, In: The Lancet. 400, 10356, p. 921-972 52 p.

    Research output: Contribution to journalReview articlepeer-review

  2. COVID-19 boosters and building trust among UK minority ethnic communities

    Nellums, L. B., Latif, A., Nkhoma, K., Timmons, S., Pareek, M., Almidani, S. & Hussain, B., 27 Aug 2022, In: The Lancet. 400, 10353, p. 643-644 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  3. Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

    Sisonke Study Team, 23 Jul 2022, In: The Lancet. 400, 10348, p. 269-271 3 p.

    Research output: Contribution to journalLetterpeer-review

  4. Menopause care and over the counter vaginal oestradiol

    Schaedel, Z. & Rymer, J., 18 Jun 2022, In: The Lancet. 399, 10343, p. 2250-2252 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  5. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2

    Antonelli, M., Pujol, J. C., Spector, T. D., Ourselin, S. & Steves, C. J., 18 Jun 2022, In: The Lancet. 399, 10343, p. 2263-2264 2 p.

    Research output: Contribution to journalLetterpeer-review

  6. Disease-modifying anti-asthmatic drugs

    Lommatzsch, M., Brusselle, G. G., Canonica, G. W., Jackson, D. J., Nair, P., Buhl, R. & Virchow, J. C., 23 Apr 2022, In: Lancet (London, England). 399, 10335, p. 1664-1668 5 p.

    Research output: Contribution to journalReview articlepeer-review

  7. Conflict in Ukraine undermines an already challenged health system

    Roborgh, S., Coutts, A. P., Chellew, P., Novykov, V. & Sullivan, R., 9 Apr 2022, In: The Lancet. 399, 10333, p. 1365-1367 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  8. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

    Sisonke Protocol Team & Sisonke Study Team, 19 Mar 2022, In: The Lancet. 399, 10330, p. 1141-1153 13 p.

    Research output: Contribution to journalArticlepeer-review

  9. COVID-19 booster doses in pregnancy and global vaccine equity

    Kalafat, E., Magee, L. A., von Dadelszen, P., Heath, P. & Khalil, A., 5 Mar 2022, In: The Lancet. 399, 10328, p. 907-908 2 p.

    Research output: Contribution to journalLetterpeer-review

  10. Report of the Lancet Commission on the Value of Death: bringing death back into life

    Lancet Commission on the Value of Death, 26 Feb 2022, In: The Lancet. 399, 10327, p. 837-884 48 p.

    Research output: Contribution to journalArticlepeer-review

  11. Mandatory COVID-19 vaccination and human rights

    King, J., Ferraz, O. L. M. & Jones, A., 15 Jan 2022, In: The Lancet. 399, 10321, p. 220-222 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  12. The Lancet Commission on diagnostics: transforming access to diagnostics

    Fleming, K. A., Horton, S., Wilson, M. L., Atun, R., DeStigter, K., Flanigan, J., Sayed, S., Adam, P., Aguilar, B., Andronikou, S., Boehme, C., Cherniak, W., Cheung, A. NY., Dahn, B., Donoso-Bach, L., Douglas, T., Garcia, P., Hussain, S., Iyer, H. S., Kohli, M., & 12 othersLabrique, A. B., Looi, L. M., Meara, J. G., Nkengasong, J., Pai, M., Pool, K. L., Ramaiya, K., Schroeder, L., Shah, D., Sullivan, R., Tan, B. S. & Walia, K., 1 Oct 2021, In: The Lancet. 398, 10315, p. 1997-2050 54 p.

    Research output: Contribution to journalArticlepeer-review

  13. SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity

    Kalafat, E., Magee, L. A., von Dadelszen, P., O'Brien, P. & Khalil, A., 11 Sep 2021, In: The Lancet. 398, 10304, p. 951 1 p.

    Research output: Contribution to journalLetterpeer-review

  14. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

    NCD Risk Factor Collaboration (NCD-RisC), 11 Sep 2021, In: The Lancet. 398, 10304, p. 957-980 24 p.

    Research output: Contribution to journalArticlepeer-review

  15. Revitalising global social medicine

    Pentecost, M., Adams, V., Baru, R., Caduff, C., Greene, J. A., Hansen, H., Jones, D. S., Kitanaka, J. & Ortega, F., 14 Aug 2021, In: The Lancet. 398, 10300, p. 573-574 2 p.

    Research output: Contribution to journalArticlepeer-review

  16. Addressing weight stigma and anti-obesity rhetoric in policy changes to prevent eating disorders

    Treasure, J. & Ambwani, S., 3 Jul 2021, In: The Lancet. 398, 10294, p. 7-8 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  17. Gain in survival after metabolic–bariatric surgery

    Mingrone, G. & Bornstein, S. R., 15 May 2021, In: The Lancet. 397, 10287, p. 1785-1787 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  18. Problems with traffic light approaches to public health emergencies of international concern

    Wenham, C., Kavanagh, M., Phelan, A., Rushton, S., Voss, M., Halabi, S., Eccleston-Turner, M. & Pillinger, M., 15 May 2021, In: The Lancet. 397, 10287, p. 1856-1858 3 p.

    Research output: Contribution to journalReview articlepeer-review

  19. New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK

    Williams, R., Alessi, C., Alexander, G., Allison, M., Aspinall, R., Batterham, R. L., Bhala, N., Day, N., Dhawan, A., Drummond, C., Ferguson, J., Foster, G., Gilmore, I., Goldacre, R., Gordon, H., Henn, C., Kelly, D., MacGilchrist, A., McCorry, R., McDougall, N., & 14 othersMirza, Z., Moriarty, K., Newsome, P., Pinder, R., Roberts, S., Rutter, H., Ryder, S., Samyn, M., Severi, K., Sheron, N., Thorburn, D., Verne, J., Williams, J. & Yeoman, A., 8 May 2021, In: The Lancet. 397, 10286, p. 1770-1780 11 p.

    Research output: Contribution to journalReview articlepeer-review

  20. Migraine: disease characterisation, biomarkers, and precision medicine

    Ashina, M., Terwindt, G. M., Al-Karagholi, M. A. M., de Boer, I., Lee, M. J., Hay, D. L., Schulte, L. H., Hadjikhani, N., Sinclair, A. J., Ashina, H., Schwedt, T. J. & Goadsby, P. J., 17 Apr 2021, In: The Lancet. 397, 10283, p. 1496-1504 9 p.

    Research output: Contribution to journalReview articlepeer-review

  21. COVID-19 vaccines in high-risk ethnic groups

    D'Souza, R. S. & Wolfe, I., 10 Apr 2021, In: The Lancet. 397, 10282, p. 1348 1 p.

    Research output: Contribution to journalLetterpeer-review

  22. Wait and see for acute dialysis: but for how long?

    Ostermann, M. & Lumlertgul, N., 3 Apr 2021, In: The Lancet. 397, 10281, p. 1241-1243 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  23. COVID-19 vaccines for Palestinians

    Watt, G., Giacaman, R., Zurayk, H., Bjertness, E., Holmboe-Ottesen, G., Ghattas, H., Nuwayhid, I., Leaning, J., Yudkin, J. S., Elessi, K., Sullivan, R., Afifi, R., Khader, Y. S. & Shannon, H. S., 13 Feb 2021, In: The Lancet. 397, 10274, p. 579 1 p.

    Research output: Contribution to journalLetterpeer-review

  24. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial

    Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., Chamseddine, G., Bornstein, S. R. & Rubino, F., 23 Jan 2021, In: The Lancet. 397, 10271, p. 293-304 12 p.

    Research output: Contribution to journalArticlepeer-review

  25. Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

    Croop, R., Lipton, R. B., Kudrow, D., Stock, D. A., Kamen, L., Conway, C. M., Stock, E. G., Coric, V. & Goadsby, P. J., 2 Jan 2021, In: The Lancet. 397, 10268, p. 51-60 10 p.

    Research output: Contribution to journalArticlepeer-review

  26. Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

    UCART19 Group, 12 Dec 2020, In: The Lancet. 396, 10266, p. 1885-1894 10 p.

    Research output: Contribution to journalArticlepeer-review

  27. Announcing the Lancet Commission on stigma and discrimination in mental health

    Thornicroft, G. & Sunkel, C., 14 Nov 2020, In: The Lancet. 396, 10262, p. 1543-1544 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  28. Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

    Grosicki, S., Simonova, M., Spicka, I., Pour, L., Kriachok, I., Gavriatopoulou, M., Pylypenko, H., Auner, H. W., Leleu, X., Doronin, V., Usenko, G., Bahlis, N. J., Hajek, R., Benjamin, R., Dolai, T. K., Sinha, D. K., Venner, C. P., Garg, M., Gironella, M., Jurczyszyn, A., & 38 othersRobak, P., Galli, M., Wallington-Beddoe, C., Radinoff, A., Salogub, G., Stevens, D. A., Basu, S., Liberati, A. M., Quach, H., Goranova-Marinova, V. S., Bila, J., Katodritou, E., Oliynyk, H., Korenkova, S., Kumar, J., Jagannath, S., Moreau, P., Levy, M., White, D., Gatt, M. E., Facon, T., Mateos, M. V., Cavo, M., Reece, D., Anderson, L. D., Saint-Martin, J. R., Jeha, J., Joshi, A. A., Chai, Y., Li, L., Peddagali, V., Arazy, M., Shah, J., Shacham, S., Kauffman, M. G., Dimopoulos, M. A., Richardson, P. G. & Delimpasi, S., 14 Nov 2020, In: The Lancet. 396, 10262, p. 1563-1573 11 p.

    Research output: Contribution to journalArticlepeer-review

  29. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    GBD 2019 Risk Factors Collaborators & Douiri, A., 17 Oct 2020, In: The Lancet. 396, 10258, p. 1223-1249 27 p.

    Research output: Contribution to journalArticlepeer-review

  30. The double burden of malnutrition—further perspective

    Osendarp, S. J. M., Brown, K. H., Neufeld, L. M., Udomkesmalee, E. & Moore, S. E., 19 Sep 2020, In: The Lancet. 396, 10254, 1 p.

    Research output: Contribution to journalLetterpeer-review

  31. A leap of faith for more effective mental health care

    Hanlon, C. & Alem, A., 29 Aug 2020, In: The Lancet. 396, 10251, p. 584-585 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  32. Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data

    Kaura, A., Sterne, J. A. C., Trickey, A., Abbott, S., Mulla, A., Glampson, B., Panoulas, V., Davies, J., Woods, K., Omigie, J., Shah, A. D., Channon, K. M., Weber, J. N., Thursz, M. R., Elliott, P., Hemingway, H., Williams, B., Asselbergs, F. W., O'Sullivan, M., Lord, G. M., & 8 othersMelikian, N., Johnson, T., Francis, D. P., Shah, A. M., Perera, D., Kharbanda, R., Patel, R. S. & Mayet, J., 29 Aug 2020, In: The Lancet. 396, 10251, p. 623-634 12 p.

    Research output: Contribution to journalArticlepeer-review

  33. The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis

    CLIP Trials Working Group, von Dadelszen, P., Bhutta, Z. A., Sharma, S., Bone, J., Singer, J. & Wong, H., 22 Aug 2020, In: The Lancet. 396, 10250, p. 553-563 11 p.

    Research output: Contribution to journalArticlepeer-review

  34. Managing late preterm pre-eclampsia – Authors' reply

    Chappell, L. C., Juszczak, E. & Shennan, A., 1 Aug 2020, In: The Lancet. 396, 10247, p. 308-309 2 p.

    Research output: Contribution to journalLetterpeer-review

  35. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., Magnolo, N., Maari, C., Feeney, C., Biswas, P., Tatulych, S., Valdez, H. & Rojo, R., 25 Jul 2020, In: The Lancet. 396, 10246, p. 255-266 12 p.

    Research output: Contribution to journalArticlepeer-review

  36. Lockdown is not egalitarian: the costs fall on the global poor

    Broadbent, A., Walker, D., Chalkidou, K., Sullivan, R. & Glassman, A., 4 Jul 2020, In: The Lancet. 396, 10243, p. 21-22 2 p.

    Research output: Contribution to journalLetterpeer-review

  37. Quantifying additional COVID-19 symptoms will save lives

    Menni, C., Sudre, C. H., Steves, C. J., Ourselin, S. & Spector, T. D., 20 Jun 2020, In: The Lancet. 395, 10241, p. e107-e108

    Research output: Contribution to journalLetterpeer-review

  38. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

    FAST-Forward Trial Management Group, 23 May 2020, In: The Lancet. 395, 10237, p. 1613-1626 14 p.

    Research output: Contribution to journalArticlepeer-review

  39. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial

    BEEP study team, 21 Mar 2020, In: The Lancet. 395, 10228, p. 962-972 11 p.

    Research output: Contribution to journalArticlepeer-review

  40. Managing cardiovascular disease risk in hypertension

    National Institute for Health and Care Excellence Hypertension (NG136) Guideline Development Group, 14 Mar 2020, In: The Lancet. 395, 10227, p. 869-870 2 p.

    Research output: Contribution to journalLetterpeer-review

  41. The psychological impact of quarantine and how to reduce it: rapid review of the evidence

    Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N. & Rubin, G. J., 14 Mar 2020, In: The Lancet. 395, 10227, p. 912-920 9 p.

    Research output: Contribution to journalReview articlepeer-review

  42. The need for an evidence-based and rational debate on e-cigarettes

    Shahab, L., Britton, J., Brown, J., Hajek, P. & McNeill, A., 29 Feb 2020, In: The Lancet. 395, 10225, 1 p.

    Research output: Contribution to journalLetterpeer-review

  43. Population-level impact of human papillomavirus vaccination

    Sasieni, P. & Cuzick, J., 8 Feb 2020, In: The Lancet. 395, 10222, 1 p.

    Research output: Contribution to journalLetterpeer-review

  44. Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK

    Williams, R., Aithal, G., Alexander, G. J., Allison, M., Armstrong, I., Aspinall, R., Baker, A., Batterham, R., Brown, K., Burton, R., Cramp, M. E., Day, N., Dhawan, A., Drummond, C., Ferguson, J., Foster, G., Gilmore, I., Greenberg, J., Henn, C., Jarvis, H., & 19 othersKelly, D., Mathews, M., McCloud, A., MacGilchrist, A., McKee, M., Moriarty, K., Morling, J., Newsome, P., Rice, P., Roberts, S., Rutter, H., Samyn, M., Severi, K., Sheron, N., Thorburn, D., Verne, J., Vohra, J., Williams, J. & Yeoman, A., 18 Jan 2020, In: The Lancet. 395, 10219, p. 226-239 14 p.

    Research output: Contribution to journalReview articlepeer-review

  45. Forgotten: mental health interventions in type 1 diabetes

    Garrett, C. & Ismail, K., 11 Jan 2020, In: The Lancet. 395, 10218, 1 p.

    Research output: Contribution to journalLetterpeer-review

Previous 1 2 3 Next

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454